| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 25,814 | 14,517 | 10,057 | 20,475 | | Cost of Revenue | 11,881 | 8,510 | 7,211 | 11,845 | | | Gross Profit | 13,933 | 6,007 | 2,846 | 8,630 | | | Operating Expenses | | Research Development | 4,100 | 3,055 | 3,239 | 4,003 | | Selling General and Administrative | 7,926 | 6,746 | 7,587 | 7,763 | | Non Recurring |
-
| 2,344 | 689 |
-
| | Others | 418 | 337 | 369 | 316 | | | | Total Operating Expenses |
-
| 12,482 | 11,884 |
-
| | | | Operating Income or Loss | 1,489 | (6,475) | (9,038) | (3,452) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 558 | (570) | (1,344) | 1,089 | | Earnings Before Interest And Taxes | 2,047 | (7,045) | (10,382) | (2,363) | | Interest Expense | 559 | 281 | 266 | 292 | | Income Before Tax | 1,488 | (7,326) | (10,648) | (2,655) | | Income Tax Expense | (83) | (360) | (20) | (14) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,571 | (6,966) | (10,628) | (2,641) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,571 | (6,966) | (10,628) | (2,641) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,571 | ($6,966) | ($10,628) | ($2,641) |
|
0.32% Nasdaq 
0.14%
Income Statement
